These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22253541)

  • 1. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease.
    Middelveen MJ; Stricker RB
    Clin Cosmet Investig Dermatol; 2011; 4():167-77. PubMed ID: 22253541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and evolution of dermal filaments from patients with Morgellons disease.
    Middelveen MJ; Mayne PJ; Kahn DG; Stricker RB
    Clin Cosmet Investig Dermatol; 2013; 6():1-21. PubMed ID: 23326202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients.
    Middelveen MJ; Bandoski C; Burke J; Sapi E; Filush KR; Wang Y; Franco A; Mayne PJ; Stricker RB
    BMC Dermatol; 2015 Feb; 15(1):1. PubMed ID: 25879673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morgellons disease: a filamentous borrelial dermatitis.
    Middelveen MJ; Stricker RB
    Int J Gen Med; 2016; 9():349-354. PubMed ID: 27789971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of spirochetal infection with Morgellons disease.
    Middelveen MJ; Burugu D; Poruri A; Burke J; Mayne PJ; Sapi E; Kahn DG; Stricker RB
    F1000Res; 2013; 2():25. PubMed ID: 24715950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of Morgellons disease: from delusion to definition.
    Middelveen MJ; Fesler MC; Stricker RB
    Clin Cosmet Investig Dermatol; 2018; 11():71-90. PubMed ID: 29467580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of Morgellons disease in a cohort of North American patients.
    Fesler MC; Middelveen MJ; Stricker RB
    Dermatol Reports; 2018 Apr; 10(1):7660. PubMed ID: 29774138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tick-borne infection in Morgellons disease patients by serological and molecular techniques.
    Middelveen MJ; Cruz ID; Fesler MC; Stricker RB; Shah JS
    Clin Cosmet Investig Dermatol; 2018; 11():561-569. PubMed ID: 30519067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and Staging of Morgellons Disease: Lessons from Syphilis.
    Middelveen MJ; Martinez RM; Fesler MC; Sapi E; Burke J; Shah JS; Nicolaus C; Stricker RB
    Clin Cosmet Investig Dermatol; 2020; 13():145-164. PubMed ID: 32104041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Morgellons disease with doxycycline.
    Zhang JF; Gopalakrishnan K; Molloy DJ
    Clin Case Rep; 2021 Dec; 9(12):e05148. PubMed ID: 34917368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease.
    Middelveen MJ; Haggblad JS; Lewis J; Robichaud GA; Martinez RM; Shah JS; Du Cruz I; Fesler MC; Stricker RB
    Clin Cosmet Investig Dermatol; 2021; 14():425-436. PubMed ID: 33986606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tick borne zoonosis: selected clinical and diagnostic aspects].
    Sambri V; Marangoni A; Storni E; Cavrini F; Moroni A; Sparacino M; Cevenini R
    Parassitologia; 2004 Jun; 46(1-2):109-13. PubMed ID: 15305697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of Morgellons disease: A patient with clinicopathologic correlation.
    Caputo V; Bonoldi E; Citterio A; Rongioletti F
    Clin Dermatol; 2022; 40(6):686-690. PubMed ID: 35905899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology.
    Savely VR; Stricker RB
    Clin Cosmet Investig Dermatol; 2010 May; 3():67-78. PubMed ID: 21437061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed
    Middelveen MJ; Filush KR; Bandoski C; Kasliwala RS; Melillo A; Stricker RB; Sapi E
    Healthcare (Basel); 2019 May; 7(2):. PubMed ID: 31108976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morgellons disease etiology and therapeutic approach: a systematic review.
    Beuerlein KG; Balogh EA; Feldman SR
    Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morgellons disease: a narrative review.
    Dib El Jalbout J; Sati H; Ghalloub P; El Bejjani G; Karam R; Mago A; Salame M; Saoudi L; Desangles AB; Emmanuel N
    Neurol Sci; 2024 Jun; 45(6):2579-2591. PubMed ID: 38319480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatological manifestations of Lyme borreliosis.
    Mullegger RR
    Eur J Dermatol; 2004; 14(5):296-309. PubMed ID: 15358567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first investigative science-based evidence of Morgellons psychogenesis.
    Roncati L; Gatti AM; Pusiol T; Piscioli F; Barbolini G; Maiorana A
    Ultrastruct Pathol; 2016; 40(5):249-53. PubMed ID: 27269255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for Ixodes holocyclus (Acarina: Ixodidae) as a vector for human lyme Borreliosis infection in Australia.
    Mayne P; Song S; Shao R; Burke J; Wang Y; Roberts T
    J Insect Sci; 2014; 14():271. PubMed ID: 25434042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.